Diabetes Board decisions

The Board remands the service connection claims for various conditions as additional medical evidence is needed to properly adjudicate the cases.

The Board remands the claims for service connection for hypertension, diabetes, hypertensive heart disease with paroxysmal atrial fibrillation and congestive heart failure (claimed as heart condition), and sleep apnea due to missing records and potential toxic exposure development.

The Board remands the matter for an addendum VA opinion addressing the nature and etiology of the Veteran's diabetes, including whether it is related to active-duty disease, event, or injury, and whether it was caused or aggravated by service-connected disabilities.

The Board granted service connection for diabetes mellitus type II and hypertension, both presumed to be related to in-service exposure to herbicide agents. Ischemic heart disease was denied.

The Board remands the issue of entitlement to special monthly compensation based on aid and attendance due to a pre-decisional duty to assist error.

The Board is remanding the claims for service connection for blurred vision, diabetes mellitus, and stroke to correct an error by the AOJ in satisfying a regulatory duty.

The Board remands the case to determine whether the Veteran's aircraft launched from his ship landed in Vietnam and to verify his participation in a toxic exposure risk activity under the PACT Act.

The Board denied service connection for left and right knee conditions, diabetes mellitus Type II, obstructive sleep apnea, and posttraumatic stress disorder.

The Board remands the claim for service connection of diabetes type 2 due to an inadequate medical opinion regarding the relationship between the Veteran's mental health disability and his diabetes.

The Board granted service connection for prostate cancer, but remanded the claims for type II diabetes mellitus, coronary artery disease, hypertension, and peripheral neuropathy of the bilateral upper extremities.

The Board denied service connection for diabetes mellitus type 2 and bilateral hearing loss, but granted service connection for erectile dysfunction/loss of use of reproductive organ.

The Board remands the matter to obtain a medical opinion regarding whether the Veteran's significant conditions at the time of his death were related to his service, including any toxic exposure risk activities (TERA), and if so, whether they had a material influence on the acceleration of his death.

The Veteran is granted special monthly compensation based on the need for regular aid and attendance due to service-connected disabilities, including PTSD and vascular dementia.

The Board denied earlier effective dates and increased ratings for service connection of coronary artery disease, diabetes mellitus, and hypertension for accrued benefits purposes.

The Board denied service connection for diabetes mellitus, hypertension, coronary artery disease, kidney disease, and left knee disability as the evidence did not support a finding that these conditions were incurred in or aggravated by active military service.

The Board granted service connection for diabetes mellitus, type II, based on the Veteran's presumed exposure to herbicide agents during active service.

The Board remands the claims for service connection for prostate cancer and type 2 diabetes mellitus to correct a pre-decisional duty to assist error related to exposure verification.

The Board granted service connection for diabetes mellitus, type II and hypertension pursuant to the PACT Act but dismissed appeals for a kidney tumor/cyst and skin cancer on the nose.

The Board denied service connection for throat cancer and diverticulitis, but remanded claims related to heart condition, hypertension, diabetes mellitus, peripheral neuropathy, erectile dysfunction, diabetic ulcer of the left foot, and a rating of total disability based on individual unemployability.

The Board denied the veteran's claims for increased rating and service connection for various conditions, including obstructive sleep apnea with asthma, metabolic syndrome, diabetes mellitus, gastroesophageal reflux disease (GERD), and hypertension.